Onconetix, Inc. (ONCO)

NCM – Real Time Price. Currency in USD

0.90

-0.07 (-7.42%)

Market open: Aug 12, 2026, 2:17 PM EDT

0.93

-0.04 (-3.76%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Entertainment Industry Agreement Reflects Real-World Adoption of Humanoid Robotics Technology Across Education, Healthcare, Hospitality, and Customer Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp. CINCINNATI, Ohio, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) is providing the following summary of a press release issued by Realbotix Corp., parent of Realbotix LLC (“Realbotix”), the target of Onconetix's previously announced pending acquisition. Realbotix has entered into an agreement with a recognized streaming platform to feature one of its humanoid robots as a robotic character in an upcoming episode of a popular Emmy-awarded television series.

05.08.2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Proteomedix Co-Founder and Proclarix® Co-Developer Returns to Company's Board; Thomas Meier, PhD Re-Elected as Chairman at Annual General Meeting CINCINNATI, Ohio , Aug. 05, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) today announced that its fully-owned Swiss subsidiary, Proteomedix AG (“PMX”), has appointed Ralph Schiess, PhD to the PMX Board of Directors. The appointment was approved at the PMX Annual General Meeting of Shareholders held on June 22, 2026, at which Thomas Meier, PhD was also re-elected to serve an additional one-year term as Chairman of the Board.

Videos

No Data

There is no data to display

Press releases

06.08.2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

05.08.2026

Onconetix, Inc. (ONCO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Onconetix, Inc. (ONCO)

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Videos

No Data

Press releases

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Videos

No Data

Press releases

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Search stocks

Onconetix, Inc. (ONCO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Onconetix, Inc. (ONCO)

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Videos

No Data

Press releases

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Videos

No Data

Press releases

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG